ERBB2 and breast carcinoma: Thus, we studied doxorubicin accumulation in HER2-expressing tumors (induced by the injection of MAMBO89 cells, established from a mammary carcinoma of a HER2 transgenic mouse) and Delta16-expressing tumors (induced by the injection of MI6 cells, established from a mammary carcinoma of a Delta16 transgenic mouse).